GammaTile Shows Promise in Newly Diagnosed Glioblastoma
PROVIDENCE, R.I., August 18, 2026 GT Medical Technologies, Inc. announced new clinical findings suggesting that its GammaTile® targeted radiation...
radiation therapy
Advertisement
IceCure Seeks NCCN Support for Breast Cancer Cryoablation
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
Fuse Oncology Unveils FuseRx to Transform Radiation Care
BOONE, N.C., July 20, 2026 Fuse Oncology has unveiled FuseRx, an innovative AI-powered prescribing and treatment-intent solution designed to...
Alpha Tau Enrolls First Immunocompromised Patient in ADMIRE
JERUSALEM, July 15, 2026 Alpha Tau Medical announced the successful treatment of the first patient in its ADMIRE clinical...
PreludeDx Expands DCIS Education Through New Collaboration
LAGUNA HILLS, Calif., July 7, 2026 PreludeDx™, a leader in precision diagnostics for early-stage breast cancer, has announced a...
Advertisements
OS Animal Health Shows Positive Phase 2 Results for OST-HER2
Rockville, Maryland, June 26, 2026 OS Animal Health announced the peer-reviewed publication of Phase 2 clinical trial results evaluating...
Vivos Submits FDA IDE for RadioGel Therapy
KENNEWICK, Wash., June 5, 2026 Vivos Inc. announced the submission of an Early Feasibility Investigational Device Exemption (IDE) application...
GT Medical Technologies Announces GammaTile Improves Survival and Reduces Recurrence in Brain Metastases
TEMPE, Ariz., May 30, 2026 GT Medical Technologies announced positive Phase 3 results from the randomized multicenter ROADS clinical...
Alpha Tau Completes Enrollment in Pivotal ReSTART cSCC Study
JERUSALEM, May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its ReSTART pivotal clinical...
KUBTEC Launches XCELL TomoRad IGRT Research System
STRATFORD, Conn., May 8, 2026 KUBTEC Scientific has launched the XCELL® TomoRad™ x-ray irradiator, a next-generation image-guided radiotherapy (IGRT)...
Advertisement
